Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 1
2018 1
2019 3
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
The chronic disease Self-Management Programme: A phenomenological study for empowering vulnerable patients with chronic diseases included in the EFFICHRONIC project.
Fracso D, Bourrel G, Jorgensen C, Fanton H, Raat H, Pilotto A, Baker G, Pisano MM, Ferreira R, Valsecchi V, Pers YM, Engberink AO. Fracso D, et al. Among authors: valsecchi v. Health Expect. 2022 Jun;25(3):947-958. doi: 10.1111/hex.13430. Epub 2022 Jan 10. Health Expect. 2022. PMID: 35014112 Free PMC article.
Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project.
Zora S, Custodero C, Pers YM, Valsecchi V, Cella A, Ferri A, Pisano-González MM, Peñacoba Maestre D, Vazquez Alvarez R, Raat H, Baker G, Pilotto A. Zora S, et al. Among authors: valsecchi v. Ther Adv Chronic Dis. 2021 Nov 20;12:20406223211056722. doi: 10.1177/20406223211056722. eCollection 2021. Ther Adv Chronic Dis. 2021. PMID: 34820081 Free PMC article.
A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis.
Pers YM, Valsecchi V, Mura T, Aouinti S, Filippi N, Marouen S, Letaief H, Le Blay P, Autuori M, Fournet D, Mercier G, Ferreira R, Jorgensen C. Pers YM, et al. Among authors: valsecchi v. Rheumatology (Oxford). 2021 Apr 6;60(4):1659-1668. doi: 10.1093/rheumatology/keaa462. Rheumatology (Oxford). 2021. PMID: 33020846 Clinical Trial.
Evaluation Design of EFFICHRONIC: The Chronic Disease Self-Management Programme (CDSMP) Intervention for Citizens with a Low Socioeconomic Position.
Tan SS, Pisano MM, Boone AL, Baker G, Pers YM, Pilotto A, Valsecchi V, Zora S, Zhang X, Fierloos I, Raat H. Tan SS, et al. Among authors: valsecchi v. Int J Environ Res Public Health. 2019 May 28;16(11):1883. doi: 10.3390/ijerph16111883. Int J Environ Res Public Health. 2019. PMID: 31142017 Free PMC article.
EFFICHRONIC study protocol: a non-controlled, multicentre European prospective study to measure the efficiency of a chronic disease self-management programme in socioeconomically vulnerable populations.
Boone ALD, Pisano-Gonzalez MM, Valsecchi V, Tan SS, Pers YM, Vazquez-Alvarez R, Peñacoba-Maestre D, Baker G, Pilotto A, Zora S, Raat H, Hevia-Fernandez JR; EFFICHRONIC Consortium. Boone ALD, et al. Among authors: valsecchi v. BMJ Open. 2019 Dec 18;9(12):e032073. doi: 10.1136/bmjopen-2019-032073. BMJ Open. 2019. PMID: 31857305 Free PMC article.
Development and Validation of a Self-Administered Multidimensional Prognostic Index to Predict Negative Health Outcomes in Community-Dwelling Persons.
Pilotto A, Veronese N, Quispe Guerrero KL, Zora S, Boone ALD, Puntoni M, Giorgeschi A, Cella A, Rey Hidalgo I, Pers YM, Ferri A, Fernandez JRH, Pisano Gonzalez M; EFFICHRONIC Consortium. Pilotto A, et al. Rejuvenation Res. 2019 Aug;22(4):299-305. doi: 10.1089/rej.2018.2103. Epub 2018 Dec 28. Rejuvenation Res. 2019. PMID: 30382001 Free PMC article.